Imperial College London

Professor Shoumitro (Shoumi) Deb

Faculty of MedicineDepartment of Brain Sciences

Visiting Professor
 
 
 
//

Contact

 

+44 (0)20 3313 4161s.deb CV

 
 
//

Location

 

Commonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@inbook{Deb:2022:10.1007/978-3-319-95720-3,
author = {Deb, S and Perera, B and Bertelli, M},
booktitle = {Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder},
doi = {10.1007/978-3-319-95720-3},
editor = {Bertelli and Deb and Munir and Hassiotis and Salvador-Carulla},
pages = {457--482},
publisher = {Springer Nature Switzerland AG 2022},
title = {Attention Defcit Hyperactivity Disorder},
url = {http://dx.doi.org/10.1007/978-3-319-95720-3},
year = {2022}
}

RIS format (EndNote, RefMan)

TY  - CHAP
AB - Attention deficit hyperactivity disorder (ADHD) is characterised by inattention or hyperactivity/ impulsivity or both. The onset of ADHD is in childhood but in a proportion of cases, some symptoms continue into adulthood. There is a strong association between ADHD, intellectual disabilities (ID), problem behaviour and autism spectrum disorder (ASD). In fact, the prevalence rate of ADHD in people persons with ID and ASD respectively is reported to be significantly higher than the general population, with a percentage ranging between e of 10% and-28%. It might be difficult to diagnose ADHD in persons with ID and low-functioning ASD. The stringent use of categorical diagnostic criteria might limit the identification of the disorder since some criteria may not be applicable, particularly for those with more severe cognitive and communication impairments. Observation of a person’s distractibility that is not consistent with their developmental level of development may help when considering the symptom of inattention in an individual with ID, while hyperactivity and impulsivity are better indicated by fidgeting most of the time, appearing ‘on the go’, and being unable to remain seated for a long time and to wait for one’s turn, which can often lead to verbal or physical aggression, irritability, mood fluctuations, or self-harming behaviour.Although ADHD in the non-ID population is a widely researched area, the lack of high-quality research on ADHD in ID has been a barrier to the advancement of treatment in this patient group, with most studies having named ID as an exclusion criterion. Drug treatment such as psychostimulants like methylphenidate along with psychosocial interventions is effective in a high proportion of cases to improve ADHD symptoms. Although the overall effect size of psychostimulant is lower than that observed in the non-ID general population despite the adverse effect profile being similar in both populations.
AU - Deb,S
AU - Perera,B
AU - Bertelli,M
DO - 10.1007/978-3-319-95720-3
EP - 482
PB - Springer Nature Switzerland AG 2022
PY - 2022///
SN - 978-3-319-95719-7
SP - 457
TI - Attention Defcit Hyperactivity Disorder
T1 - Textbook of Psychiatry for Intellectual Disability and Autism Spectrum Disorder
UR - http://dx.doi.org/10.1007/978-3-319-95720-3
ER -